Harbour Capital Advisors’s Apellis Pharmaceuticals APLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-9,487	Closed	-$477K	–	258
2022 Q4	$477K	Buy	9,487 +2,717	+40%	+$137K	0.16%	132
2022 Q3	$392K	Buy	+6,770	New	+$392K	0.14%	145